SM

Sunitha Muhammed

Active Director Director DIN 09246507
DIN 09246507 First appointment Jul 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sunitha Muhammed

Data last updated:

Sunitha Muhammed is a Director at St Elizabath Multi Speciality Hospitals And Research Centers Limited (since 2021). The company operates in Healthcare.

DIN 09246507
Primary Designation Director
Industry Healthcare
First Appointment 20 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jul 20212021Active

Directorship timeline

Open interactive timeline →
St Elizabath Multi Speciality Hospitals And Research Centers Limited
Premium access

Shareholding and investment profile for Sunitha Muhammed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunitha Muhammed

Sunitha Muhammed currently holds 1 directorship: St Elizabath Multi Speciality Hospitals And Research Centers Limited (Director, since 20 Jul 2021).

Sunitha Muhammed was first appointed on 20 Jul 2021 as Director at St Elizabath Multi Speciality Hospitals And Research Centers Limited.

The current boards of Sunitha Muhammed's companies include Ajees Muhammed (St Elizabath Multi Speciality Hospitals And Research Centers Limited), Rajamuhammed (St Elizabath Multi Speciality Hospitals And Research Centers Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available